Cargando…

Treatment outcome of new culture positive pulmonary tuberculosis in Norway

BACKGROUND: The key elements in tuberculosis (TB) control are to cure the individual patient, interrupt transmission of TB to others and prevent the tubercle bacilli from becoming drug resistant. Incomplete treatment may result in excretion of bacteria that may also acquire drug resistance and cause...

Descripción completa

Detalles Bibliográficos
Autores principales: Farah, Mohamed Guled, Tverdal, Aage, Steen, Tore W, Heldal, Einar, Brantsaeter, Arne B, Bjune, Gunnar
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549556/
https://www.ncbi.nlm.nih.gov/pubmed/15698472
http://dx.doi.org/10.1186/1471-2458-5-14
_version_ 1782122432354582528
author Farah, Mohamed Guled
Tverdal, Aage
Steen, Tore W
Heldal, Einar
Brantsaeter, Arne B
Bjune, Gunnar
author_facet Farah, Mohamed Guled
Tverdal, Aage
Steen, Tore W
Heldal, Einar
Brantsaeter, Arne B
Bjune, Gunnar
author_sort Farah, Mohamed Guled
collection PubMed
description BACKGROUND: The key elements in tuberculosis (TB) control are to cure the individual patient, interrupt transmission of TB to others and prevent the tubercle bacilli from becoming drug resistant. Incomplete treatment may result in excretion of bacteria that may also acquire drug resistance and cause increased morbidity and mortality. Treatment outcome results serves as a tool to control the quality of TB treatment provided by the health care system. The aims of this study were to evaluate the treatment outcome for new cases of culture positive pulmonary TB registered in Norway during the period 1996–2002 and to identify factors associated with non-successful treatment. METHODS: This was a register-based cohort study. Treatment outcome was assessed according to sex, birthplace, age group, isoniazid (INH) susceptibility, mode of detection and treatment periods (1996–1997, 1998–1999 and 2000–2002). Logistic regression was also used to estimate the odds ratio for treatment success vs. non-success with 95% confidence interval (CI), taking the above variables into account. RESULTS: Among the 655 patients included, the total treatment success rate was 83% (95% CI 80%–86%). The success rates for those born in Norway and abroad were 79% (95% CI 74%–84%) and 86% (95% CI 83%–89%) respectively. There was no difference in success rates by sex and treatment periods. Twenty-two patients (3%) defaulted treatment, 58 (9%) died and 26 (4%) transferred out. The default rate was higher among foreign-born and male patients, whereas almost all who died were born in Norway. The majority of the transferred out group left the country, but seven were expelled from the country. In the multivariate analysis, only high age and initial INH resistance remained as significant risk factors for non-successful treatment. CONCLUSION: Although the TB treatment success rate in Norway has increased compared to previous studies and although it has reached a reasonable target for treatment outcome in low-incidence countries, the total success rate for 1996–2002 was still slightly below the WHO target of success rate of 85%. Early diagnosis of TB in elderly patients to reduce the death rate, abstaining from expulsion of patients on treatment and further measures to prevent default could improve the success rate further.
format Text
id pubmed-549556
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5495562005-02-25 Treatment outcome of new culture positive pulmonary tuberculosis in Norway Farah, Mohamed Guled Tverdal, Aage Steen, Tore W Heldal, Einar Brantsaeter, Arne B Bjune, Gunnar BMC Public Health Research Article BACKGROUND: The key elements in tuberculosis (TB) control are to cure the individual patient, interrupt transmission of TB to others and prevent the tubercle bacilli from becoming drug resistant. Incomplete treatment may result in excretion of bacteria that may also acquire drug resistance and cause increased morbidity and mortality. Treatment outcome results serves as a tool to control the quality of TB treatment provided by the health care system. The aims of this study were to evaluate the treatment outcome for new cases of culture positive pulmonary TB registered in Norway during the period 1996–2002 and to identify factors associated with non-successful treatment. METHODS: This was a register-based cohort study. Treatment outcome was assessed according to sex, birthplace, age group, isoniazid (INH) susceptibility, mode of detection and treatment periods (1996–1997, 1998–1999 and 2000–2002). Logistic regression was also used to estimate the odds ratio for treatment success vs. non-success with 95% confidence interval (CI), taking the above variables into account. RESULTS: Among the 655 patients included, the total treatment success rate was 83% (95% CI 80%–86%). The success rates for those born in Norway and abroad were 79% (95% CI 74%–84%) and 86% (95% CI 83%–89%) respectively. There was no difference in success rates by sex and treatment periods. Twenty-two patients (3%) defaulted treatment, 58 (9%) died and 26 (4%) transferred out. The default rate was higher among foreign-born and male patients, whereas almost all who died were born in Norway. The majority of the transferred out group left the country, but seven were expelled from the country. In the multivariate analysis, only high age and initial INH resistance remained as significant risk factors for non-successful treatment. CONCLUSION: Although the TB treatment success rate in Norway has increased compared to previous studies and although it has reached a reasonable target for treatment outcome in low-incidence countries, the total success rate for 1996–2002 was still slightly below the WHO target of success rate of 85%. Early diagnosis of TB in elderly patients to reduce the death rate, abstaining from expulsion of patients on treatment and further measures to prevent default could improve the success rate further. BioMed Central 2005-02-07 /pmc/articles/PMC549556/ /pubmed/15698472 http://dx.doi.org/10.1186/1471-2458-5-14 Text en Copyright © 2005 Farah et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Farah, Mohamed Guled
Tverdal, Aage
Steen, Tore W
Heldal, Einar
Brantsaeter, Arne B
Bjune, Gunnar
Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title_full Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title_fullStr Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title_full_unstemmed Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title_short Treatment outcome of new culture positive pulmonary tuberculosis in Norway
title_sort treatment outcome of new culture positive pulmonary tuberculosis in norway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC549556/
https://www.ncbi.nlm.nih.gov/pubmed/15698472
http://dx.doi.org/10.1186/1471-2458-5-14
work_keys_str_mv AT farahmohamedguled treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway
AT tverdalaage treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway
AT steentorew treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway
AT heldaleinar treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway
AT brantsaeterarneb treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway
AT bjunegunnar treatmentoutcomeofnewculturepositivepulmonarytuberculosisinnorway